Am. J. Respir. Crit. Care Med., Vol 153, No. 5, 05 1996, 1519-1529.
Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking
B Pedersen, R Dahl, R Karlstrom, CG Peterson and P Venge
Department of Lung Medicine, University Hospital, Arhus, Denmark.
The object of this investigation was to study the long-term effects of
antiasthma treatment on blood markers of inflammation and lung function in
adult asthmatic subjects. For this purpose 85 allergic and nonallergic
asthmatic subjects were randomized into three groups, which were given
high-dose (1,600 micrograms/d) inhaled budesonide, low-dose (400
micrograms/d) inhaled budesonide, and oral theophylline (600 mg/d),
respectively, and were followed for 11 mo with testing of lung function and
blood sampling for the assay in serum of eosinophil cationic protein (ECP),
eosinophil protein x/eosinophil derived neurotoxin (EPX/EDN) as eosinophil
markers, and myeloperoxidase (MPO) and lactoferrin (LF) as neutrophil
markers. Lung functions (FEV1% predicted, and histamine PC20) and the
eosinophil markers ECP and EPX/EDN were improved and reduced, respectively,
by budesonide in a dose-dependent and temporally parallel fashion.
Theophylline did not alter lung functions but reduced ECP and EPX/EDN after
prolonged treatment. The treatment efficacy of budesonide was attributed
solely to an effect on nonsmoking asthmatic subjects, since neither lung
functions nor eosinophil markers changed in smokers even with high-dose
budesonide. MPO but not LF was reduced after several months of treatment in
all three groups, but only in nonsmokers. We conclude that ECP and EPX/EDN
may be used to monitor antiinflammatory treatment in asthmatic patients,
and that smoking asthmatic subjects are resistant to inhaled
corticosteroids.
This article has been cited by other articles:

|
 |

|
 |
 
L. Bjermer
Review: Evaluating combination therapies for asthma: pros, cons, and comparative benefits
Therapeutic Advances in Respiratory Disease,
June 1, 2008;
2(3):
149 - 161.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Braganza, R. Chaudhuri, and N. C. Thomson
Review: Treating patients with respiratory disease who smoke
Therapeutic Advances in Respiratory Disease,
April 1, 2008;
2(2):
95 - 107.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Thomson
Smokers with Asthma: What Are the Management Options?
Am. J. Respir. Crit. Care Med.,
April 15, 2007;
175(8):
749 - 750.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-P. Boulet, C. Lemiere, F. Archambault, G. Carrier, M. C. Descary, and F. Deschesnes
Smoking and Asthma: Clinical and Radiologic Features, Lung Function, and Airway Inflammation
Chest,
March 1, 2006;
129(3):
661 - 668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Dijkstra, J M Vonk, H Jongepier, G H Koppelman, J P Schouten, N H T ten Hacken, W Timens, and D S Postma
Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex
Thorax,
February 1, 2006;
61(2):
105 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Janson, R. de Marco, S. Accordini, E. Almar, M. Bugiani, A. Carolei, L. Cazzoletti, I. Cerveri, A. Corsico, E. Duran-Tauleria, et al.
Changes in the use of anti-asthmatic medication in an international cohort
Eur. Respir. J.,
December 1, 2005;
26(6):
1047 - 1055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D D Sin, L Wu, J A Anderson, N R Anthonisen, A S Buist, P S Burge, P M Calverley, J E Connett, B Lindmark, R A Pauwels, et al.
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease
Thorax,
December 1, 2005;
60(12):
992 - 997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J E M Tomlinson, A D McMahon, R Chaudhuri, J M Thompson, S F Wood, and N C Thomson
Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma
Thorax,
April 1, 2005;
60(4):
282 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Powell and P G Gibson
Initial starting dose of inhaled corticosteroids in adults with asthma: a systematic review
Thorax,
December 1, 2004;
59(12):
1041 - 1045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N.C. Thomson, R. Chaudhuri, and E. Livingston
Asthma and cigarette smoking
Eur. Respir. J.,
November 1, 2004;
24(5):
822 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes
Corticosteroid Resistance in Airway Disease
Proceedings of the ATS,
November 1, 2004;
1(3):
264 - 268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Bateman, H. A. Boushey, J. Bousquet, W. W. Busse, T. J. H. Clark, R. A. Pauwels, S. E. Pedersen, and for the GOAL Investigators Group
Can Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma ControL Study
Am. J. Respir. Crit. Care Med.,
October 15, 2004;
170(8):
836 - 844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yamasawa, K. Oshikawa, S. Ohno, and Y. Sugiyama
Macrolides Inhibit Epithelial Cell-Mediated Neutrophil Survival by Modulating Granulocyte Macrophage Colony-Stimulating Factor Release
Am. J. Respir. Cell Mol. Biol.,
April 1, 2004;
30(4):
569 - 575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Bel
Smoking: A Neglected Cause of Glucocorticoid Resistance in Asthma
Am. J. Respir. Crit. Care Med.,
December 1, 2003;
168(11):
1265 - 1266.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chaudhuri, E. Livingston, A. D. McMahon, L. Thomson, W. Borland, and N. C. Thomson
Cigarette Smoking Impairs the Therapeutic Response to Oral Corticosteroids in Chronic Asthma
Am. J. Respir. Crit. Care Med.,
December 1, 2003;
168(11):
1308 - 1311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P S Burge, P M A Calverley, P W Jones, S Spencer, and J A Anderson
Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study
Thorax,
August 1, 2003;
58(8):
654 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G W Chalmers, K J Macleod, S A Little, L J Thomson, C P McSharry, and N C Thomson
Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma
Thorax,
March 1, 2002;
57(3):
226 - 230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Chalmers, K. J. MacLeod, L. Thomson, S. A. Little, C. McSharry, and N. C. Thomson
Smoking and Airway Inflammation in Patients With Mild Asthma
Chest,
December 1, 2001;
120(6):
1917 - 1922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. GRUNBERG, R. F. SHARON, J. K. SONT, J. C. C. M. IN'T VEEN, W. A. A. M. VAN SCHADEWIJK, E. P. A. DE KLERK, C. R. DICK, J. H. J. M. VAN KRIEKEN, and P. J. STERK
Rhinovirus-induced Airway Inflammation in Asthma . Effect of Treatment with Inhaled Corticosteroids before and during Experimental Infection
Am. J. Respir. Crit. Care Med.,
November 15, 2001;
164(10):
1816 - 1822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Emelyanov, G. Fedoseev, A. Abulimity, K. Rudinski, A. Fedoulov, A. Karabanov, and P. J. Barnes
Elevated Concentrations of Exhaled Hydrogen Peroxide in Asthmatic Patients
Chest,
October 1, 2001;
120(4):
1136 - 1139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J C Kips and R A Pauwels
Low dose inhaled corticosteroids and the prevention of death from asthma
Thorax,
September 1, 2001;
56(90002):
ii74 - 78.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Lipworth, C. M. Jackson, A. De Maria, G. W. Canonica, D. W. Reid, A. Soltani, H. Walters, S. O'Connor, R. Wise, J. Connett, et al.
Inhaled Triamcinolone and Chronic Obstructive Pulmonary Disease
N. Engl. J. Med.,
May 17, 2001;
344(20):
1553 - 1556.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Belda, J. Giner, P. Casan, and J. Sanchis
Mild Exacerbations and Eosinophilic Inflammation in Patients With Stable, Well-Controlled Asthma After 1 Year of Follow-up
Chest,
April 1, 2001;
119(4):
1011 - 1017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Daffern, M. A. Jagels, and T. E. Hugli
Multiple Epithelial Cell-Derived Factors Enhance Neutrophil Survival . Regulation by Glucocorticoids and Tumor Necrosis Factor-alpha
Am. J. Respir. Cell Mol. Biol.,
August 1, 1999;
21(2):
259 - 267.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev.,
June 1, 1999;
51(2):
213 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Sippel, K. L. Pedula, W. M. Vollmer, A. S. Buist, and M. L. Osborne
Associations of Smoking With Hospital-Based Care and Quality of Life in Patients With Obstructive Airway Disease
Chest,
March 1, 1999;
115(3):
691 - 696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. TURNER, K. NOERTJOJO, S. VEDAL, T. BAI, S. CRUMP, and J. MARK FITZGERALD
Risk Factors for Near-fatal Asthma . A Case-Control Study in Hospitalized Patients with Asthma
Am. J. Respir. Crit. Care Med.,
June 1, 1998;
157(6):
1804 - 1809.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|